65 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/0c/e4/6b/0ce46b91-3d22-279b-52fe-d3b1a2a47107/mza_11625791986367831883.jpg/600x600bb.jpg

TMO EPM / Hemato H9J

64 episodes

4 days ago

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

RSS

All content for TMO EPM / Hemato H9J is the property of TMO EPM / Hemato H9J and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38086306/38086306-1762344159090-11c00800cf3b7.jpg

65 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

TMO EPM / Hemato H9J

33 minutes 32 seconds

6 days ago

65 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Discussão do artigo: "Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma" de Wang M JCO 2025

Apresentado por: Dra. Ana Cecilia Bahia

Discussão por: Dr. Gabriele Ritter, Dr. Matheus Garcia, Dr. Pedro Moraes e Dr. Vinícius Molla